TCM
TARO

Touradji Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Touradji Capital Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,300
Closed -$327K – 78
2013
Q3 		$327K Sell
4,300
-200
-4% -$13K 1.01% 33
2013
Q2 		$252K Buy
+4,500
New +$266K 0.94% 39

Other funds holding TARO

IC
ISZO Capital New York $135M AUM
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
VCAM
Valentine Capital Asset Management Danville, California $89.6M AUM 0.84% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Touradji Capital Management's TARO Position: Q4 2013 in Review

Touradji Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2013, closing a stake of 4,300 shares — an estimated $327K sold.

Touradji Capital Management first reported a position in TARO in Q2 2013 and held it in 2 quarters. The position peaked at $327K in Q3 2013. 55 funds tracked by Wall St. Rank hold TARO as of Q4 2013.

  • Touradji Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2013 after selling out during the quarter.
  • Touradji Capital Management sold 4,300 Taro Pharmaceutical Industries Ltd. shares in Q4 2013, an estimated $327K.
  • Touradji Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 2 quarters.
  • Touradji Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $327K in Q3 2013.
  • 55 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2013.

Based on Touradji Capital Management's 13F filing for Q4 2013, filed 11 Feb 2014.